Articles by Disease (Renal Cell Carcinoma)

Cellular Localisation of Chromogranins and Processed Products in the Diffuse Neuroendocrine System and Related Tumours

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 4
Page: 149-160
Author(s): Mats Stridsberg, Eva T. Janson and Guida M. Portela-Gomes

Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 4
Page: 161-168
Author(s): Angelo Corti and Elisabetta Ferrero

Antifolates - Past, Present and Future

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4
Page: 405-410
Author(s): Aleem Gangjee and Hiteshkumar D. Jain

p53: Fighting Cancer

Journal: Current Cancer Drug Targets
Volume: 4
Page: 385-402
Author(s): Galina Selivanova

Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation

Journal: Current Cancer Drug Targets
Volume: 4
Page: 403-424
Author(s): M. C. Liu, J. L. Marshall and R. G. Pestell

Antisense Strategies

Journal: Current Molecular Medicine
Volume: 4
Page: 465-487
Author(s): Stanley T. Crooke

Therapeutic Antibodies

Journal: Current Molecular Medicine
Volume: 4
Page: 539-547
Author(s): Bernd Groner, Cord Hartmann and Winfried Wels

Consequences of Elevated Homocysteine During Embryonic Development and Possible Modes of Action

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2719-2732
Author(s): P. R. Brauer and B. J. Tierney

Osteoblast Differentiation and Control by Vitamin D and Vitamin D Metabolites

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2535-2555
Author(s): M. Driel van, H. A.P. Pols and J.P. T.M. van Leeuwen

Retracted: Effects of Vitamin K2 on Osteoporosis

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2557-2576
Author(s): Jun Iwamoto*, Tsuyoshi Takeda and Yoshihiro Sato